Phillip M Galbo

14PUBLICATIONS
56CO-AUTHORS
Cancer cell biologyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 18, 2025
H2AK119ub dynamics control hair follicle stem cell quiescence.

Pooja Flora, Meng Yen Li, Yudong Zhou

|Jun 19, 2024
Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity.

Zhixin Jing, Phillip Galbo, Luis Ovando

|May 08, 2024
TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors.

Christopher D Nishimura, Devin Corrigan, Xiang Yu Zheng

|Jan 03, 2024
TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells.

Hao Wang, R Alejandro Sica, Gurbakhash Kaur

|Dec 07, 2023
Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma.

Phillip M Galbo, Anne Tranberg Madsen, Yang Liu

|Apr 27, 2022
The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development.

Elodie Picarda, Phillip M Galbo, Haihong Zong

Pageof 3

Frequent Collaborators

10 joint publications

Deyou Zheng

6 joint publications

Xingxing Zang

3 joint publications

Yao Wei

2 joint publications

Katherine L Morel